DURHAM, N.C. – A partnership between Validic and Dexcom is establishing one of the first multi-measure platforms to stream patient generated health data (PGHD) directly into existing clinical workflows.
The integrated platform will help patients become more engaged in managing their own health and it will enable physicians to offer more personalized treatment, said Drew Schiller, CEO of Validic.
“With the use of PGHD, providers have deeper insight into their patients’ behavior and lifestyle on a daily basis and can identify readings or trends that may indicate an impending negative health event or negative patterns,” he said.
Chronic diseases affect about 133 million people in the U.S., according to the National Health Council. That number is expected to reach 157 million by 2020, including 81 million people with multiple chronic conditions.
As the number of patients with chronic conditions like diabetes and hypertension continues to rise, so too does the need for more continuous, personalized care, Schiller said.
“With this integration, we enable care providers to offer more proactive, preventive care—allowing them to spend less time checking in, and more time helping out,” he said.
Through the partnership, continuous glucose monitoring data from Dexcom’s cloud application program interface is integrated into Validic’s Inform data connectivity platform. When the data is integrated directly into the clinical workflow, providers can access and incorporate PGHD from CGMs, sleep and activity trackers, and other devices into care plans to better manage chronic and post-acute conditions, Schiller said. The addition of machine learning and analytics capabilities enables more personalized, automated treatment.
The Validic platform allows PGHD to appear in the stream in near real-time—making Dexcom CGM data available every five minutes.
Schiller said data from the Dexcom G5 and G6 mobile apps and other contextual data will be integrated into the Validic platform.